Anzeige
❌
Mehr »
Freitag, 25.09.2026 - Börsentäglich über 12.000 News
GALLIUM WAR NUR DER ANFANG: Atlanticos Vier-Metall-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
333 Leser
Artikel bewerten:
(1)

Earth Life Sciences, Inc.: Earth Life Sciences New Domain Name for Viva Health Services

The VIVA health platform improves the efficiency of supply and co-ordinating demand

RENO, NV / ACCESSWIRE / October 6, 2021 / Earth Life Sciences Inc. (OTC PINK:CLTS) ("Company") announces that pursuant to the acquisition agreement with VIVA Health HK Limited, ("Viva Health"), the Company will launch a new website to handle health services in the United States called www.VivaBestHealth.com.

Through technical advances such as artificial intelligence and big data, Viva Health is building a platform in the USA optimising the functions of health care staff training management, health care service management and quality control. The customized platform to address American needs is to provide services through the mode of online ordering and offline service ("O2O"), the services being a one-stop smart life service branded platform, oriented to the health care industry.

The Company aims to make VIVA Health into a leading one-stop smart life service platform in the United States.

According to PolicyAdvice.net, the global healthcare sector will reach $10.059 trillion by 2022. [i] The United States spends significantly more on healthcare, per capita, compared to other nations and such spending is expected to continue growing.

The care of the ever expanding aging population and the development of medical technology have become a huge driving force for the healthcare industry, and the United States will usher in a new era. It is the largest sector in the field of big health. CMS {"Content Management System"} data has shown that national healthcare spending hit a total of $3.8 trillion in the year before the onset of COVID-19. [ii]

The VIVA USA platform will standardize the output of brand images, service processes, service content and training systems, as well as upgrade professional skills and service quality for healthcare service through online and offline learning and assessment.

In the near future, VIVA USA will be available to land in most of the United States, covering hundreds of cities and towns and serving millions of users and families. The company is committed to providing a full range of professional nursing services in particular for millions of Asian and other families in North America. This includes hospital nursing, home care, customized nursing, companions for the elderly, confinement nannies, family nannies, babysitters, and so on.

Based on its business development strategy in the United States, VIVA intends to raise US$1.1 million initially and to further expand its business in the USA.

About Earth Life Sciences Inc.

In its efforts to enhance shareholder value, Earth Life Sciences is embarking into a new and exciting segment of Personal Care, one of the fastest growing portions of the multi-trillion-dollar Health Care industry.

The Company's developer, Viva USA is a company with extensive experience in creating similar systems.

Earth Life Sciences has recent AI (Artificial Intelligence) experience and will assist in customization and implementation of advanced innovative software platform which will facilitate the delivery of on-site Life Style Services and well being to families across the United States under the banner of VIVA USA.

EARTH LIFE SCIENCES INC.
ANGELO MARINO
CEO
1-514-500-4111
info@earthlifesciences.com
info@vivabesthealth.com

Forward-Looking Information

This press release contains forward-looking statements. The words "believe," "desirous," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

[i] https://policyadvice.net/insurance/insights/healthcare-statistics/

[ii] https://revcycleintelligence.com/news/us-healthcare-spending-hit-high-of-3.8t-after-rising-4.6-in-2019

SOURCE: Earth Life Sciences, Inc.



View source version on accesswire.com:
https://www.accesswire.com/666975/Earth-Life-Sciences-New-Domain-Name-for-Viva-Health-Services

© 2021 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.